These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 11747332

  • 1. Loss of heterozygosity on chromosomes 11 and 17 are markers of recurrence in TCC of the bladder.
    Edwards J, Duncan P, Going JJ, Grigor KM, Watters AD, Bartlett JM.
    Br J Cancer; 2001 Dec 14; 85(12):1894-9. PubMed ID: 11747332
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Chromosome 9 deletions and recurrence of superficial bladder cancer: identification of four regions of prognostic interest.
    Simoneau M, LaRue H, Aboulkassim TO, Meyer F, Moore L, Fradet Y.
    Oncogene; 2000 Dec 14; 19(54):6317-23. PubMed ID: 11175346
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Molecular serological diagnosis in transitional cell bladder cancer.
    von Knobloch R, Brandt H, Hofmann R.
    Ann N Y Acad Sci; 2004 Jun 14; 1022():70-5. PubMed ID: 15251942
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Association between recurrence of sporadic colorectal cancer, high level of microsatellite instability, and loss of heterozygosity at chromosome 18q.
    Sarli L, Bottarelli L, Bader G, Iusco D, Pizzi S, Costi R, D'Adda T, Bertolani M, Roncoroni L, Bordi C.
    Dis Colon Rectum; 2004 Sep 14; 47(9):1467-82. PubMed ID: 15486743
    [Abstract] [Full Text] [Related]

  • 12. Chromosomal high-polysomies predict tumour progression in T1 transitional cell carcinoma of the bladder.
    Ribal MJ, Alcaraz A, Mengual L, Carrio A, Lopez-Guillermo A, Mallofré C, Palou J, Gelabert A, Villavicencio H.
    Eur Urol; 2004 May 14; 45(5):593-9. PubMed ID: 15082201
    [Abstract] [Full Text] [Related]

  • 13. Loss of P16 expression and chromosome 9p21 LOH in predicting outcome of patients affected by superficial bladder cancer.
    Bartoletti R, Cai T, Nesi G, Roberta Girardi L, Baroni G, Dal Canto M.
    J Surg Res; 2007 Dec 14; 143(2):422-7. PubMed ID: 17612565
    [Abstract] [Full Text] [Related]

  • 14. Transitional cell bladder tumor: predicting recurrence and progression by analysis of microsatellite loss of heterozygosity in urine sediment and tumor tissue.
    Fornari D, Steven K, Hansen AB, Jepsen JV, Poulsen AL, Vibits H, Horn T.
    Cancer Genet Cytogenet; 2006 May 14; 167(1):15-9. PubMed ID: 16682280
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Detection of loss of heterozygosity in the p53 tumor-suppressor gene with PCR in the urine of patients with bladder cancer.
    Friedrich MG, Erbersdobler A, Schwaibold H, Conrad S, Huland E, Huland H.
    J Urol; 2000 Mar 14; 163(3):1039-42. PubMed ID: 10688045
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.